Review




Structured Review

Procell Inc human ovarian carcinoma (oc) cell lines
Fisetin inhibited the proliferation of both <t>human</t> ovary <t>carcinoma</t> <t>cell</t> <t>lines</t> (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment
Human Ovarian Carcinoma (Oc) Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ovarian carcinoma (oc) cell lines/product/Procell Inc
Average 90 stars, based on 1 article reviews
human ovarian carcinoma (oc) cell lines - by Bioz Stars, 2026-05
90/100 stars

Images

1) Product Images from "Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis"

Article Title: Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis

Journal: Journal of Ovarian Research

doi: 10.1186/s13048-022-00984-4

Fisetin inhibited the proliferation of both human ovary carcinoma cell lines (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment
Figure Legend Snippet: Fisetin inhibited the proliferation of both human ovary carcinoma cell lines (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment

Techniques Used: MTT Assay



Similar Products

90
Procell Inc human ovarian carcinoma (oc) cell lines
Fisetin inhibited the proliferation of both <t>human</t> ovary <t>carcinoma</t> <t>cell</t> <t>lines</t> (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment
Human Ovarian Carcinoma (Oc) Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human ovarian carcinoma (oc) cell lines/product/Procell Inc
Average 90 stars, based on 1 article reviews
human ovarian carcinoma (oc) cell lines - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Fisetin inhibited the proliferation of both human ovary carcinoma cell lines (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment

Journal: Journal of Ovarian Research

Article Title: Fisetin-induced cell death in human ovarian cancer cell lines via zbp1-mediated necroptosis

doi: 10.1186/s13048-022-00984-4

Figure Lengend Snippet: Fisetin inhibited the proliferation of both human ovary carcinoma cell lines (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment

Article Snippet: Human ovarian carcinoma (OC) cell lines were obtained from Procell (Procell, China) and cultured in DMEM (HyClone, USA) supplemented with 10% fetal bovine serum (Gibco, USA) and 1% penicillin–streptomycin (Sigma, USA).

Techniques: MTT Assay